Posts tagged: Tiziana Life Sciences

Tiziana Life Sciences back under the spotlight... - Part 12

Friday, 19 June 2020, 10:32 pm

Investors that have taken a punt on Tiziana Life Sciences in recent weeks were nicely rewarded today after the shares closed up almost 27pc.

In part, the shares surged because the company - which is working on treatments for a variety of diseases, including Covid 19 - was awarded a key patent.

Below is the link to today's announcement in case you missed it:..

Read more...

Tiziana Life Sciences back under the spotlight... - Part 10

Thursday, 4 June 2020, 5:52 am

It's that time of the week when Betaville writes about Tiziana Life Sciences, the Aim-listed biopharmceutical developer.

Well, readers might recall that last Friday I suggested there are all sorts of things brewing at Tiziana Life Sciences.

And I understand some fresh data could emerge in the next week that could be transformational for the business, making Tiziana Life Sciences of interest to the pharmaceutical giants...

Read more...

Tiziana Life Sciences back under the spotlight... - Part 6

Friday, 22 May 2020, 6:18 am

The buzz around Tiziana Life Sciences grows louder.

This is because there is talk circulating the market the company could be involved some major corporate activity over the next couple of weeks.

However, don't expect an imminent takeover bid for the whole business from Exact Sciences Corporation. That seems unlikely for a while, said people following the situation...

Read more...

Tiziana Life Sciences back under the spotlight... - Part 5

Monday, 18 May 2020, 6:45 am

Small cap enthusiasts will be watching to see how shares of Aim-listed Tiziana Life Sciences reacts this morning after its US ADR stock shot up 10pc on Friday evening on large volume.

Last week, Tiziana unveiled the details of a Royal Marseden trial for StemPrintER, its stem cell biology-based genomic tool for the prediction of disease recurrence in breast cancer patients, at the ASCO conference...

Read more...

Tiziana Life Sciences back under the spotlight... - Part 4

Thursday, 14 May 2020, 7:38 am

There will be plenty of small cap punters watching Tiziana Life Sciences this morning after it released details of a new study on StemPrintER, its stem cell biology-based genomic tool for the prediction of disease recurrence in breast cancer patients, at the ASCO conference last night.

Below is a link to an interview with Tiziana's chief executive Gabriele Cerrone, who has been working on the test over the last seven years...

Read more...

Tiziana Life Sciences back under the spotlight... - Part 3

Wednesday, 29 April 2020, 8:09 am

I have had a few enquiries about whether Tiziana's new new combinational therapy was the one announced just a few hours after the publication of Betaville's piece on Monday.

People familiar with the matter have confirmed the announcement on Monday lunchtime is the new combinational therapy referred to in my piece on Monday. I have pasted the link to the company announcement below:..

Read more...

Tiziana Life Sciences back under the spotlight...

Thursday, 9 April 2020, 12:07 am

Small cap enthusiasts might want to keep an eye on Aim-listed Tiziana Life Sciences.

Word reaches Betaville that the company has developed a unique approach for the fight against Coronavirus.

In case you don't recall Tiziana's shares soared over 200pc last month during one trading session after it launched plans to fastrack a drug it thinks could treat some of the more severe symptons of Coronavirus...

Read more...